Showing results (71-80 of 187) with videos related to
Sort By:
Pageof 19
American Journal of Human Genetics|February 15, 2003
Use of multivariate linkage analysis for dissection of a complex cognitive traitAngela J Marlow, Simon E Fisher, Clyde Francks, et al.Journal of Hepatology|December 15, 2010
Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinomaChun-Fang Xu, Brian H Reck, Vicki L Goodman, et al.Genome Research|February 10, 2006
The portability of tagSNPs across populations: a worldwide surveyAnna González-Neira, Xiayi Ke, Oscar Lao, et al.Gastroenterology|October 13, 2006
TUCAN (CARD8) genetic variants and inflammatory bowel diseaseDermot P B McGovern, Helen Butler, Tariq Ahmad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injuryDaniel J Schaid, Colin F Spraggs, Shannon K McDonnell, et al.Human Reproduction (Oxford, England)|December 13, 2006
Significant evidence of one or more susceptibility loci for endometriosis with near-Mendelian inheritance on chromosome 7p13-15Krina T Zondervan, Susan A Treloar, Jianghai Lin, et al.Annals of Human Genetics|December 22, 2006
The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onsetJ Michael Andresen, Javier Gayán, Luc Djoussé, et al.Human Molecular Genetics|May 23, 2002
Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factorsDavid A van Heel, Irina A Udalova, Arjuna P De Silva, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancerColin F Spraggs, Laura R Budde, Linda P Briley, et al.Nature Genetics|June 30, 2015
The support of human genetic evidence for approved drug indicationsMatthew R Nelson, Hannah Tipney, Jeffery L Painter, et al.Pageof 19